Skip to main content
Fig. 7 | Cancer Cell International

Fig. 7

From: BTG1 inhibits malignancy as a novel prognosis signature in endometrial carcinoma

Fig. 7

BTG1 inhibits the malignant biological behavior of ECC. a The EDU test was used to determine the effect of BTG1 on the proliferation of Ishikawa and HEC-1A cell lines. b Wound healing assay is used to determine the effect of BTG1 on the migration of Ishikawa and HEC-1A cell lines. c Transwell invasion assay to determine the effect of BTG1 on the invasion ability of Ishikawa and HEC-1A cell lines. d Cell apoptosis assay was used to analyze the effect of BTG1 on the apoptosis of Ishikawa and HEC-1A cell lines. The data are expressed as mean ± SEM (n = 3, each group). *P < 0.05, **P < 0.01 and ***P < 0.001

Back to article page